Clinical Trial Update: Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1) [Phase 3]

View source ↗

Summary

ROMANA 1 is a Phase 3 trial evaluating the safety and efficacy of anamorelin HCl in patients with non-small cell lung cancer-associated cachexia; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cachexia
• Non-small Cell Lung Cancer

Drugs mentioned

• Anamorelin HCl (anamorelin hydrochloride)

Snippet

Sponsor: Helsinn Therapeutics (U.S.), Inc | Conditions: Cachexia, Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-07-11